Ongoing research in the field of Cardiac Markers

Written by Dr. Nithin Jayan, MBBS, DNB

Medically Reviewed by Dr. Sunil Shroff, MBBS, MS, FRCS (UK), D. Urol (Lond)

Last Updated on Jul 04, 2018

Ongoing research in the field of Cardiac Markers

Owing to the vitality of cardiac markers active researches are being carried out. Some of the targets include:

Standardization of methods for measuring current markers, troponin I in particular.
The assessment of rapid bedside tests
To investigate the relationship between cardiac markers and emerging immunological coagulation parameters.

References:

Cecil Medicine, 23rd Ed. Harrison's PRINCIPLES OF INTERNAL MEDICINE, 17^TH Edition
Cardiovasc Pathol. 2007 Nov-Dec;16(6):329-35. Epub 2007 Jun 20.
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH Volume 29, Number 2, 56-63, DOI: 10.1007/s005990050064

Published on Nov 11, 2010
Last Updated on Jul 04, 2018

Comments

Randox Monday, November 15, 2010

The ischemic biomarker Heart-type Fatty Acid Binding Protein [H-FABP] can substantially improve the detection of high risk patients when Troponin-negative, even when a high sensitivity assay is used, a new publication has shown. In the June edition of JACC, Professor Alistair Hall and colleagues from the University of Leeds, UK, prospectively studied a cohort of 1080 consecutive patients admitted to hospital with suspected ACS and compared the H-FABP assay (Randox Laboratories) with the high sensitivity Ultra-TnI assay (Siemens Healthcare Diagnostics).